Obstetrics & Gynecology Doctors in Dearborn, MI Accepting Medicare

67 Obstetrics & Gynecology doctors found. Showing 61 - 67

Petra Chamseddine, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5500 Auto Club Dr, Dearborn, MI 48126 Phone: 313-425-4567

Salil S Khandwala, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 22731 Newman St Ste 200, Dearborn, MI 48124 Phone: 313-982-0200    Fax: 313-982-0500

Billie Zidel, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-436-2582

David Moses, MD Obstetrics & Gynecology - Maternal & Fetal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2142 Monroe St Ste 100, Dearborn, MI 48124 Phone: 313-481-1030    Fax: 313-481-1031

Dr. Jodi Robinson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 25080 Michigan Ave, Dearborn, MI 48124 Phone: 313-730-8880    Fax: 313-730-1167

Dr. Julie Diane Mladic, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4900 Mercury Dr Ste 201, Dearborn, MI 48126 Phone: 313-790-8000

Anjum Bokhari, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2421 Monroe St Ste 201, Dearborn, MI 48124 Phone: 313-447-0511

News Archive

Lemon-lime soft drink could improve effectiveness of oral anticancer drug: Study

Experiments with an artificial stomach suggest that a popular lemon-lime soft drink could play an unexpected role in improving the effectiveness of an oral anticancer drug. The experiments produced evidence that patients will absorb more of the unnamed drug, tested in Phase I in clinical trials, when taken with "flat" or degassed Sprite. The study appears in ACS' Molecular Pharmaceutics, a bi-monthly journal.

Six genomics research projects receive grants to address the role of ethnicity in major cancers

Leading cancer scientists working with the New York Genome Center (NYGC) announced today that grants are being awarded to fund six projects that address the role of ethnicity in several major cancer types, taking advantage of the diversity of patients being treated at health care institutions throughout the New York City area.

FDA clears first computer-aided device to assist in the detection of heart murmurs

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp, announced today it has received U.S. Food and Drug Administration (FDA) clearance to market Zargis Acoustic Cardioscan (Cardioscan), the first and only computer-aided medical device to support physicians in analyzing heart sounds for the identification of suspected murmurs, a potential sign of heart disease.

InVivo Therapeutics reports net income of $3,067,000 for third quarter 2011

InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and nine months ended September 30, 2011 and provided a business update.

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3
• 4(current)